Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04530591 · ClinicalTrials.gov registry record
User Acceptability of a Device-Based Opioid Overdose Intervention
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 97
- Enrollment target
NCT04530591: Completed study, sponsored by University of Pennsylvania.
NCT04530591 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04530591 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
This pilot study evaluates the needs of opioid users for a device-based intervention for opioid overdoses. The results of this one-time short questionnaire will inform development of a novel naloxone delivery device.
Interventions
- OTHER Interview
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2020-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04530591
The ClinicalTrials.gov registry entry for NCT04530591 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Interview is the first listed.
NCT04530591 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04530591 about?
NCT04530591 is a clinical study titled "User Acceptability of a Device-Based Opioid Overdose Intervention". This pilot study evaluates the needs of opioid users for a device-based intervention for opioid overdoses. The results of this one-time short questionnaire will inform development of a novel naloxone delivery device.
What is the current status of trial NCT04530591?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2020-08-25. Estimated completion is 2020-09-15.
What interventions are being tested in trial NCT04530591?
The interventions under investigation include: Interview (OTHER), Survey (OTHER).
Who is sponsoring clinical trial NCT04530591?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.